RASopathies

Gene: A2ML1

Red List (low evidence)

A2ML1 (alpha-2-macroglobulin like 1)
EnsemblGeneIds (GRCh38): ENSG00000166535
EnsemblGeneIds (GRCh37): ENSG00000166535
OMIM: 610627, Gene2Phenotype
A2ML1 is in 4 panels

3 reviews

Zornitza Stark (Australian Genomics)

Red List (low evidence)

Four unrelated individuals reported with de novo missense variants in this gene, zebrafish model. However, p.Arg802His is present in 168 heterozygotes in gnomad and one homozygote; p.Arg802Leu is also present in 168 heterozygotes, 1 homozygote; and p.Arg592Leu is present in 105 heterozygotes. Rated as DISPUTED by ClinGen.
Created: 3 Jul 2020, 10:16 a.m. | Last Modified: 3 Jul 2020, 10:16 a.m.
Panel Version: 1.55

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Noonan syndrome

Publications

Ellen McDonagh (Genomics England Curator)

Still a lack of evidence for this gene-disease at this time.
Created: 1 Jun 2018, 1:50 p.m.
PMID: 25862627 - one patient described as having a A2ML1 variant but unable to verify whether this is a seperate individual from those previously described.
Created: 1 Jun 2018, 1:47 p.m.
Comment on publications: PMID: 27942422 - review article.
Created: 1 Jun 2018, 1:43 p.m.
Comment on publications: PMID: 24939586 - three families reported with missense variants in this gene in affected individuals, although unaffected individuals in two families did not have genotyping carried out to see if they were not carriers, and one unaffected family member in the 2nd family had the variant but no clinical features. Variants were identified in ESP. Zebrafish with these variants showed noonan-syndrome-like developmental defects, including a broad head, blunted face and cardiac malformations. All three variants are described as variants of unknown significance at this time on OMIM, and the gene is not linked to a disease.
Created: 1 Jun 2018, 1:32 p.m.
Tord Jonson (Dep. of Clinical Genetics & Pathology, Lund, Sweden) reviewed this gene as Red on the intellectual disability panel as a candidate rasopathy gene and provided additional publications (https://panelapp.genomicsengland.co.uk/panels/285/gene/A2ML1/).
Created: 1 Jun 2018, 1:28 p.m.
Gene added by expert review. Comment from Reviewer: Gain of function mutations linked with Noonan syndrome-like disorder. Contribution to patients' phenotypes still unconfirmed. - Helen Savage (Congenica Ltd), Jan. 21, 2016, 4:44 p.m.
Created: 5 Feb 2016, 12:54 p.m.
Comment on list classification: The presented paper is published - see PMID, which also provides functional evidence of the mutation found in a patient. Variants of unknown significance reported on OMIM/ClinVar as the association with Noonan syndrome-like disorders/rasopathies is not yet confirmed. This gene should remain red until further evidence arises.
Created: 5 Feb 2016, 9:27 a.m.

Helen Savage (Congenica Ltd)

Red List (low evidence)

Paper presented at the annual meeting of the American Society of Human Genetics, San Francisco, 6-10 November 2012: Yntema, H., W. Nillesen, J. Paardekooper Overman, M. Bonetti, J. de Ligt, H. Venselaar, M. Tartaglia, S. G. M. Frints, L. E. L. M. Vissers, J. den Hertog, I. van der Burgt. (2012) The identification of a novel gene identified by exome sequencing reveals the upstream components of the RAS/MAPK signaling pathway involved in Noonan syndrome.

Likely gain of function mutations.
Created: 1 Feb 2016, 10:54 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Noonan syndrome

Mode of pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Red
Phenotypes
  • Noonan syndrome
OMIM
610627
Clinvar variants
Variants in A2ML1
Penetrance
Complete
Publications
Mode of Pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments
Panels with this gene

History Filter Activity

1 Jun 2018, Gel status: 1

Set publications

Ellen McDonagh (Genomics England Curator)

Publications for gene: A2ML1 were set to 24939586; 25862627; 27942422

1 Jun 2018, Gel status: 1

Set publications

Ellen McDonagh (Genomics England Curator)

Publications for gene: A2ML1 were set to 24939586; 25862627; 27942422

1 Jun 2018, Gel status: 1

Set publications

Ellen McDonagh (Genomics England Curator)

Publications for gene: A2ML1 were set to 24939586; 25862627; 27942422

1 Jun 2018, Gel status: 1

Set publications

Ellen McDonagh (Genomics England Curator)

Publications for gene: A2ML1 were set to PMID: 24939586; 25862627; 27942422

5 Feb 2016, Gel status: 1

Set publications

Ellen McDonagh (Genomics England Curator)

Publications for A2ML1 were set to PMID: 24939586

5 Feb 2016, Gel status: 1

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Red List (Low Evidence).

5 Feb 2016, Gel status: 1

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Red List (Low Evidence).

5 Feb 2016, Gel status: 1

Set publications

Ellen McDonagh (Genomics England Curator)

Publications for A2ML1 were set to PubMed: 24939586

2 Feb 2016, Gel status: 1

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Red List (Low Evidence).

1 Feb 2016, Gel status: 0

Added New Source

Helen Savage (Congenica Ltd)

A2ML1 was added to RASopathiespanel. Sources: Other

1 Feb 2016, Gel status: 0

Created

Helen Savage (Congenica Ltd)

A2ML1 was created by helen.savage